BENIGN PROSTATIC HYPERPLASIA TREATMENT SYSTEM
Minimally invasive treatment methods for benign prostatic hyperplasia (BPH) tissue. A system includes a sustained release formulation comprising a cytostatic or cytotoxic drug, and an applicator or delivery system for local delivery of a composition comprising or consisting essentially of the sustai...
Gespeichert in:
Hauptverfasser: | , , |
---|---|
Format: | Patent |
Sprache: | eng ; fre ; ger |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | |
---|---|
container_issue | |
container_start_page | |
container_title | |
container_volume | |
creator | TROLLSAS, Olof Mikael STANKUS, John J GHOLAMI, Shahram Shawn |
description | Minimally invasive treatment methods for benign prostatic hyperplasia (BPH) tissue. A system includes a sustained release formulation comprising a cytostatic or cytotoxic drug, and an applicator or delivery system for local delivery of a composition comprising or consisting essentially of the sustained release formulation to the prostate. The applicator containing the composition is characterized by a KIR value of between 15 and 1,000 Centipoise per unit area. |
format | Patent |
fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_EP4469108A1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>EP4469108A1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_EP4469108A13</originalsourceid><addsrcrecordid>eNrjZNB1cvXzdPdTCAjyDw5xDPF0VvCIDHANCvBxDPZ0VAgJcnUM8XX1C1EIjgwOcfXlYWBNS8wpTuWF0twMCm6uIc4euqkF-fGpxQWJyal5qSXxrgEmJmaWhgYWjobGRCgBAKEbJYM</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>BENIGN PROSTATIC HYPERPLASIA TREATMENT SYSTEM</title><source>esp@cenet</source><creator>TROLLSAS, Olof Mikael ; STANKUS, John J ; GHOLAMI, Shahram Shawn</creator><creatorcontrib>TROLLSAS, Olof Mikael ; STANKUS, John J ; GHOLAMI, Shahram Shawn</creatorcontrib><description>Minimally invasive treatment methods for benign prostatic hyperplasia (BPH) tissue. A system includes a sustained release formulation comprising a cytostatic or cytotoxic drug, and an applicator or delivery system for local delivery of a composition comprising or consisting essentially of the sustained release formulation to the prostate. The applicator containing the composition is characterized by a KIR value of between 15 and 1,000 Centipoise per unit area.</description><language>eng ; fre ; ger</language><subject>DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY ; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR ; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROMTHE BODY ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE</subject><creationdate>2024</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20241204&DB=EPODOC&CC=EP&NR=4469108A1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25542,76289</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20241204&DB=EPODOC&CC=EP&NR=4469108A1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>TROLLSAS, Olof Mikael</creatorcontrib><creatorcontrib>STANKUS, John J</creatorcontrib><creatorcontrib>GHOLAMI, Shahram Shawn</creatorcontrib><title>BENIGN PROSTATIC HYPERPLASIA TREATMENT SYSTEM</title><description>Minimally invasive treatment methods for benign prostatic hyperplasia (BPH) tissue. A system includes a sustained release formulation comprising a cytostatic or cytotoxic drug, and an applicator or delivery system for local delivery of a composition comprising or consisting essentially of the sustained release formulation to the prostate. The applicator containing the composition is characterized by a KIR value of between 15 and 1,000 Centipoise per unit area.</description><subject>DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY</subject><subject>DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR</subject><subject>DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROMTHE BODY</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2024</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZNB1cvXzdPdTCAjyDw5xDPF0VvCIDHANCvBxDPZ0VAgJcnUM8XX1C1EIjgwOcfXlYWBNS8wpTuWF0twMCm6uIc4euqkF-fGpxQWJyal5qSXxrgEmJmaWhgYWjobGRCgBAKEbJYM</recordid><startdate>20241204</startdate><enddate>20241204</enddate><creator>TROLLSAS, Olof Mikael</creator><creator>STANKUS, John J</creator><creator>GHOLAMI, Shahram Shawn</creator><scope>EVB</scope></search><sort><creationdate>20241204</creationdate><title>BENIGN PROSTATIC HYPERPLASIA TREATMENT SYSTEM</title><author>TROLLSAS, Olof Mikael ; STANKUS, John J ; GHOLAMI, Shahram Shawn</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_EP4469108A13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; fre ; ger</language><creationdate>2024</creationdate><topic>DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY</topic><topic>DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR</topic><topic>DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROMTHE BODY</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><toplevel>online_resources</toplevel><creatorcontrib>TROLLSAS, Olof Mikael</creatorcontrib><creatorcontrib>STANKUS, John J</creatorcontrib><creatorcontrib>GHOLAMI, Shahram Shawn</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>TROLLSAS, Olof Mikael</au><au>STANKUS, John J</au><au>GHOLAMI, Shahram Shawn</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>BENIGN PROSTATIC HYPERPLASIA TREATMENT SYSTEM</title><date>2024-12-04</date><risdate>2024</risdate><abstract>Minimally invasive treatment methods for benign prostatic hyperplasia (BPH) tissue. A system includes a sustained release formulation comprising a cytostatic or cytotoxic drug, and an applicator or delivery system for local delivery of a composition comprising or consisting essentially of the sustained release formulation to the prostate. The applicator containing the composition is characterized by a KIR value of between 15 and 1,000 Centipoise per unit area.</abstract><oa>free_for_read</oa></addata></record> |
fulltext | fulltext_linktorsrc |
identifier | |
ispartof | |
issn | |
language | eng ; fre ; ger |
recordid | cdi_epo_espacenet_EP4469108A1 |
source | esp@cenet |
subjects | DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROMTHE BODY HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE |
title | BENIGN PROSTATIC HYPERPLASIA TREATMENT SYSTEM |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-07T20%3A19%3A18IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=TROLLSAS,%20Olof%20Mikael&rft.date=2024-12-04&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EEP4469108A1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |